Audited Financial Results along with Audit Report for quarter and year ended 31.03.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gayatri BioOrganics Ltd reported zero revenue from operations for both Q4 and FY 2025-26, indicating no active business operations. The company posted a net loss of Rs 111.18 lakhs for FY 2025-26 compared to a loss of Rs 72.65 lakhs in the previous year, representing a 53% increase in losses. Total expenses stood at Rs 111.18 lakhs primarily comprising employee costs (Rs 11.29 lakhs), finance costs (Rs 35.77 lakhs), and other expenses (Rs 64.12 lakhs). The balance sheet shows negative other equity of Rs 11,579.31 lakhs, indicating massive accumulated losses eroding shareholder funds. Cash used in operating activities was Rs 73.54 lakhs. The auditors issued an unmodified opinion but included an Emphasis of Matter drawing attention to undisclosed notes.
The company is essentially non-operational with zero revenue and mounting losses. The negative equity of Rs 11,579.31 lakhs signals severe financial distress. The going concern basis relies solely on a promoter comfort letter, creating significant risk for shareholders.